Medical/Pharmaceuticals
Millions of Women who Suffer from Pelvic Pain Still Unaware of Pelvic Venous Congestion Syndrome PVCS
SYDNEY, Oct. 20, 2022 /PRNewswire/ -- Pelvic pain is a common condition
affecting millions of women around the world, with up to 40% affected during
their lifetime. Of those affected, 30% suffer from Pelvic Venous Congestion
Syndrome (PVCS). Boston Scientific haslaunched a new website
2022-10-20 10:00
2614
Telix Reports Third Quarter 2022 Financial Results
MELBOURNE, Australia, Oct. 20, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended30 September 2022 (Q3 2022). All figures are in AUD$ unless otherwise...
2022-10-20 06:09
2634
On World Osteoporosis Day, take five steps to better bone health
NYON, Switzerland, Oct. 20, 2022 /PRNewswire/ -- Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis prevention. Osteoporosis is a bone disease that affects some 500...
2022-10-20 06:00
2640
Biostarks Designated As Official Biomarker Testing Kit of the Global Ironman Triathlon Series and Title Partner of the 2022 Ironman Arizona Triathlon, Part of the Vinfast Ironman U.S. Series
SOUTH JORDAN, Utah, Oct. 19, 2022 /PRNewswire/ -- Biostarks, a preventative health and wellness company, recently announced a multi-year partnership as the Official Biomarker Testing Kit of the Global IRONMAN® Triathlon Series. The partnership kicked offOct. 6 & 8, 2022 at the 2022 VinFast IRONMA...
2022-10-19 21:00
2073
NCCN Guidelines for Patients Win Award for Excellence in Cancer Patient Education from CPEN
National Comprehensive Cancer Network's breast cancer patient resources honored for unique support of diversity, equity, and inclusion, available free at NCCN.org/patientresources. PLYMOUTH MEETING, Pa., Oct. 19, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance ...
2022-10-19 20:37
1897
Everest Medicines Announces Partner Providence Reports Positive Top-Line Data from Phase 2 Primary Immunization Trial for mRNA COVID-19 Vaccine Candidate in Adults
-- Levels of neutralizing antibodies generated by PTX-COVID19-B were non-inferior to Comirnaty®-- -- PTX-COVID19-B was well tolerated with no safety signals-- -- Everest is filing IND applications for phase 3 clinical trials for booster indication-- SHANGHAI, Oct. 19, 2022 /PRNewswire/ -- Everest...
2022-10-19 20:15
4215
Brii Biosciences Presents Promising Clinical Data to Support Ongoing Development of Novel HIV Therapeutic Candidates at IDWeek 2022
* Findings from two Phase 1 studies show both BRII-732 and BRII-778 are safe and well-tolerated * Results indicate potential for oral once-weekly, long-acting combination therapy for HIV infection, supporting continued clinical development * Additional data presented by Brii's licensing part...
2022-10-19 20:00
3766
EDAN Forays into Molecular Point-of-Care Market with Its First-Ever Molecular Diagnostics Solution Released at Medlab Asia 2022
Developed based on Loop-Mediated Isothermal Amplification (LAMP), the new molecular diagnostics analysis system, ClariLight CL30, gives on-the-spot results and empowers physicians for early infectious disease diagnostics because of its agility, fast and flexibility. BANGKOK, Thailand, Oct. 19, 2...
2022-10-19 19:59
3294
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 26 at 10:00 CEST
GOTHENBURG, Sweden, Oct. 19, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the presen...
2022-10-19 15:30
2172
MedAlliance to be Acquired by Cordis
GENEVA, Oct. 19, 2022 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of$35M and upfront closing payment of$200M, regulatory achievement milestones of up to $125M ...
2022-10-19 08:00
3403
The Grand Hamdan Award goes to two scientists in Australia
DUBAI, UAE, Oct. 19, 2022 /PRNewswire/ -- According to an official announcement
made recently inDubai, Prof. Ian Hector Frazer and the Late Dr. Jian Zhou are
the winners of the Grand Hamdan Award for the topic of – Infectious Diseases in
the Award's 12th term (2021-2022).
2022-10-19 04:05
2393
CEM Introduces the Future of Microwave Digestion
MATTHEWS, N.C., Oct. 18, 2022 /PRNewswire/ -- CEM Corporation, a leading supplier of sample preparation systems, is pleased to introduce the all new BLADETM automated microwave digestion system. The BLADE brings speed, simplicity, flexibility, and performance to elemental sample preparation. CEM ...
2022-10-18 21:52
3462
Rhovac board member resigns due to health reasons
LUND, Sweden, Oct. 18, 2022 /PRNewswire/ -- RhoVac AB (publ) announces today, October 18th 2022, that board member and co-founder Anders Ljungqvist is resigning from the board at his own request due to health reasons. Gunnar Gårdemyr, chairman of the board, comments: "On behalf of the board, I w...
2022-10-18 21:29
2048
Alphyn Biologics Announces Enrollment Passes Halfway Point in Phase2a Clinical Trial of Mild-to-Moderate Atopic Dermatitis Treatment
Study evaluates AB-101a for patients with and without concurrent bacterial infection ANNAPOLIS, Md., Oct. 18, 2022 /PRNewswire/ -- Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today that enrollment in its Phase2a clinical t...
2022-10-18 19:30
2477
TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM
* OPALESCENCE Phase II feasibility study of TLX250-CDx in patients with triple-negative breast cancer – early results suggest potential to detect carbonic anhydrase IX (CAIX) expression, theranostic potential in this difficult to treat disease. * PERTINENCE Early Phase I feasibility study of ...
2022-10-18 06:43
2356
GenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) - the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new products.
SINGAPORE, Oct. 17, 2022 /PRNewswire/ -- GenScript ProBio (a global one-stop CDMO from GenScript Group) today announced a strategic collaboration with Hibiocy Co. Ltd., a private corporation based inBangkok, Thailand, to accelerate a respiratory-care medical device, COVITRAP™ which contains human...
2022-10-17 23:56
7403
Value of Tissue Analytics for Remote Care Highlighted in Research From Australian Virtual Wound Care Program
PITTSBURGH and SYDNEY, Oct. 17, 2022 /PRNewswire/ -- Net Health, a leading provider of specialty electronic health record (EHR) systems and advanced healthcare analytics, announced results from a first-of-its-kind study for a promising wound care treatment model. The findings showed Net Health® T...
2022-10-17 20:00
2045
Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology
* Brings Eyenuk's total funding to over $43 million * Funding round led by AXA IM Alts; joined by T&W Medica A/S, Kendall Capital Partners, and others * Eyenuk adds three new board members * Funding affirms Eyenuk's standing as the global leader among developers of autonomous AI solutions ...
2022-10-17 19:30
2288
Kira Pharmaceuticals to Present First-in-Human Clinical Data at American Society for Nephrology Kidney Week 2022
Phase 1 biomarker data confirms proof of mechanism with dose-dependent and potent inhibition of alternative and terminal pathways with KP104 via dual-targeting mechanism Data demonstrated KP104 was safe and well tolerated, and supports further investigation of KP104 in Phase 2 clinical studies ...
2022-10-17 19:00
2959
Collaboration Between Drug and Medical Food Manufacturers to Boost Market's Growth
Frost & Sullivan says the prevalence of lifestyle diseases and geriatric population drives demand for medical food globally SAN ANTONIO, Oct. 17, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Medical Food Growth Opportunities, finds that the rising consumer awareness about the i...
2022-10-17 17:21
1822
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 274 media titles]
2026-10-09 13:21Southeast Asia's China travel map is widening, Traveloka platform data shows
[Picked up by 263 media titles]
2026-10-05 11:51Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
9127
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
8163
DayOne Files Registration Statement for Proposed Initial Public Offering
2026-10-06 05:28
7981